postmenopausal osteoporosis
Conditions
Interventions
Denosumab injections Group:None
Control Group:None
Sponsors
Xi'an Honghui Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
Female
Age
45 Years to 85 Years
Inclusion criteria
Inclusion criteria: The following criteria must all be met for trial inclusion: 1. Postmenopausal women aged between 45 and 85 years. 2. Conformance to the Western medicine diagnostic criteria for postmenopausal osteoporosis. 3. Those who have received at least two treatments of Denosumab injection. 4. Detailed records of initial and follow-up medical histories, along with comprehensive examination results. 5. Willingness to participate in this study.
Exclusion criteria
Exclusion criteria: To be eligible for the trial, all of the following criteria must be not met: 1.Patients with secondary osteoporosis. 2.Patients who are allergic to the study drug. 3.Patients with hypocalcemia. 4.Patients who participate in other clinical trials during the treatment period. 5.Any other conditions deemed inappropriate for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density; | — |
Secondary
| Measure | Time frame |
|---|---|
| ß-CrossLaps;Human N-terminal midfragmen of Osteocalcin;Serum Calcium 2+;Vitamin D;Parathyroid Hormone;Body Mass Index; | — |
Countries
China
Contacts
Public ContactWang jun
Xi'an Honghui Hospital of Xi'an Jiaotong University
Outcome results
None listed